Figure 1
Figure 1. Sustained neutrophil engraftment after myeloablative double-unit CBT by infused viable CD34+ cell dose per kilogram of the dominant unit (n = 128). Neutrophil engraftment was significantly associated with the dominant unit infused viable CD34+ cell dose.

Sustained neutrophil engraftment after myeloablative double-unit CBT by infused viable CD34+ cell dose per kilogram of the dominant unit (n = 128). Neutrophil engraftment was significantly associated with the dominant unit infused viable CD34+ cell dose.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal